LABORAS™: Initial pharmacological validation of a system allowing continuous monitoring of laboratory rodent behaviour (Q44635393)

4 December 2017

title

LABORAS: Initial pharmacological validation of a system allowing continuous monitoring of laboratory rodent behaviour (English)

1 reference

4 December 2017

LABORAS™: Initial pharmacological validation of a system allowing continuous monitoring of laboratory rodent behaviour (English)

1 reference

https://api.crossref.org/works/10.1016/S0165-0270(03)00227-9

26 March 2024

1 reference

Brenda Trail

3

1 reference

4 December 2017

Andrew Billinton

6

1 reference

4 December 2017

Neil Upton

7

1 reference

4 December 2017

Leann P. Quinn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583407

26 March 2024

Tania O. Stean

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583407

26 March 2024

Mark S. Duxon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583407

26 March 2024

Sharon C. Stratton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583407

26 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14583407

26 March 2024

publication date

1 November 2003

1 reference

4 December 2017

30 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14583407

full work available at URL

26 March 2024

https://api.elsevier.com/content/article/PII:S0165027003002279?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0165-0270(03)00227-9

https://api.elsevier.com/content/article/PII:S0165027003002279?httpAccept=text/plain

26 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0165-0270(03)00227-9

Journal of Neuroscience Methods

26 March 2024

published in

1 reference

4 December 2017

volume

130

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

83-92

1 reference

Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2803%2900227-9

7 January 2021

Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2803%2900227-9

7 January 2021

Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT(1A) receptor antagonist WAY100635.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2803%2900227-9

7 January 2021

Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2803%2900227-9

7 January 2021

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2803%2900227-9

7 January 2021

Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2803%2900227-9

7 January 2021

Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2803%2900227-9

7 January 2021

Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2803%2900227-9

7 January 2021

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2803%2900227-9

7 January 2021

SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2803%2900227-9

7 January 2021

Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2803%2900227-9

7 January 2021

Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2803%2900227-9

7 January 2021

Subfornical organ: site of drinking elicitation by angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2803%2900227-9

7 January 2021

Localization of receptors for the dipsogenic action of angiotensin II in the subfornical organ of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2803%2900227-9

7 January 2021

The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2803%2900227-9

7 January 2021

Development of tolerance and reverse tolerance to haloperidol- and SCH23390-induced cataleptic effects during withdrawal periods after long-term treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2803%2900227-9

7 January 2021

Validation of a new system for the automatic registration of behaviour in mice and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2803%2900227-9

7 January 2021

Identifiers

1 reference

4 December 2017

1 reference